Clinical Trials Logo

Conjunctivitis, Allergic clinical trials

View clinical trials related to Conjunctivitis, Allergic.

Filter by:

NCT ID: NCT01203540 Completed - Clinical trials for Allergic Conjunctivitis

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Start date: October 2010
Phase: Phase 4
Study type: Interventional

Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device. Evaluation of the effects and safety of NAABAK® through inflammation markers and symptoms in patients with allergic conjunctivitis and dry eye syndrome after 3 months treatment. The patients will attend 4 visits.

NCT ID: NCT01174823 Completed - Clinical trials for Allergic Conjunctivitis

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Start date: June 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.

NCT ID: NCT01159769 Completed - Clinical trials for Allergic Conjunctivitis

Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis

Start date: June 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate patient perceptions of olopatadine 0.2% dosed once daily in patients previously treated with twice-daily, topical, ocular, anti-allergy medications.

NCT ID: NCT01159015 Completed - Clinical trials for Allergic Conjunctivitis

Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers

Start date: July 2010
Phase: Phase 3
Study type: Interventional

This study is being conducted to evaluate the safety of KetoNaph ophthalmic solution in healthy adult subjects and in pediatric subjects with a history or family history of ocular allergy.

NCT ID: NCT01134328 Completed - Clinical trials for Allergic Conjunctivitis

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CACâ„¢ Model

Start date: May 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CACâ„¢ Model.

NCT ID: NCT01120132 Completed - Clinical trials for Allergic Conjunctivitis

Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic Conjunctivitis

Start date: May 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy and safety of the administration of cyclosporine and prednisolone acetate compared to placebo in the treatment of allergic conjunctivitis.

NCT ID: NCT01119287 Completed - Clinical trials for Allergic Conjunctivitis

Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study was to evaluate the efficacy of Maxidex and Patanol compared to placebo in patients with allergic conjunctivitis when exposed to controlled allergen levels in an Environmental Exposure Chamber (EEC).

NCT ID: NCT01111279 Completed - Clinical trials for Seasonal Allergic Rhinoconjunctivitis

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Start date: March 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of gpASIT+TM administered subcutaneously in absence or in presence of an immunoregulating adjuvant in grass pollen allergic patients.

NCT ID: NCT01109485 Completed - Clinical trials for Allergic Conjunctivitis

Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The objective of this study is to further evaluate the safety of Olopatadine Ophthalmic Solution 0.1% in Japanese children with allergic conjunctivitis.

NCT ID: NCT01107405 Completed - Clinical trials for Allergic Conjunctivitis

Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen Challenge

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of loteprednol etabonate ophthalmic base, compared to loteprednol etabonate ophthalmic suspension, and vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in a modified Conjunctival Allergen Challenge model and in an environmental model during pollen season. Comparisons will be made following 2 weeks of dosing.